Benzodiazepines can be beneficial when prescribed short-term. However, these medications are not risk-free especially when combined with other controlled substance. Despite the risk, these medications continue to be used widely for the treatment of depression, anxiety, pain and sleep disorders. Pharmacists are the most appropriate healthcare providers in identifying the risk associated with these drugs and bring the awareness to patients and their providers. Pharmacists need to have an increased awareness of the risk associated with these medications when used both short and long terms. In this session, two experts in the field will focus on the identification of patients at increased risk for adverse outcomes secondary to these medications, compare strategies for discontinuation and develop protocols that minimize withdrawal symptoms.
At the completion of this application-based activity, participants will be able to:
- Explain the risks, patterns, and benefits associated with use of benzodiazepines.
- Identify patients at increased risk of adverse outcomes secondary to benzodiazepines.
- Compare evidence-based nonpharmacologic and pharmacologic strategies for benzodiazepine discontinuation.
- Design a protocol based on patient-specific characteristics that minimizes withdrawal symptoms.
Activity type: Application-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-158-H01-P
To obtain credit for completing Sounding the Alarm of Benzodiazepine, participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.Initial release date: April 1, 2020
Expiration date: March 20, 2023 - No credit granted after this date
Sounding the Alarm of Bezodiazepine is an activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association
Jeffery Gold and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2020 Virtual Education package.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-158-H01-P||0.15 CEUs||March 20, 2020 - March 20, 2023|